Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis
Titel:
Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis
Auteur:
Parsels, Katie A. Seabury, Robert W. Zyck, Stephanie Miller, Christopher D. Krishnamurthy, Satish Darko, William Probst, Luke A. Latorre, Julius Gene Cwikla, Gregory M. Feldman, Elizabeth A.